Stay updated on Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the error page.
    Difference
    0.2%
    Check dated 2026-10-19T03:01:12.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page displays site revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-12T02:37:54.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study content. This indicates that access to the study record is blocked and users are presented with an error screen instead of study details.
    Difference
    17%
    Check dated 2026-09-21T00:43:35.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Adds a 2015 (U.S. NIH Grant/Contract) funding line and updates the site revision to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-30T22:22:57.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the study record documentation.
    Difference
    0.0%
    Check dated 2026-08-09T11:34:04.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision tag updated to v3.6.4, indicating the current build of the page. It replaces the previous v3.6.3.
    Difference
    0.0%
    Check dated 2026-07-25T18:17:38.000Z thumbnail image

Stay in the know with updates to Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nintedanib vs Placebo in Scleroderma Lung Fibrosis Clinical Trial page.